Eye-Tracking device shows promise for faster autism diagnosis in kids
NCT ID NCT05806216
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a device called EarliPoint that tracks where children look while watching short videos. The goal was to see if it could help diagnose autism spectrum disorder (ASD) in children ages 2.5 to 7. Nearly 1,000 children participated, and the device's results were compared to a diagnosis from an expert clinician. The study also looked at whether the device could measure verbal and nonverbal abilities.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
EarliPoint System (a device that tracks eye movements while children watch videos)
What this could lead to
If successful, this device could provide a faster, more objective way to diagnose autism in young children, potentially leading to earlier support and intervention.
What could go wrong
This is a completed study, but the device may not be as accurate as expert diagnosis for all children. It is a diagnostic tool, not a treatment, and its real-world usefulness depends on further validation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cincinnati Childrens Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Emory University - Marcus Autism Center
Altanta, Georgia, 30329, United States
-
Monroe-Meyer Institute for Genetics and Rehabilitation / University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
-
Seattle Children's Hospital
Seattle, Washington, 98115, United States
-
Southwest Autism Research and Resource Center
Phoenix, Arizona, 85006, United States
-
ThompsonCenter for Autism & Neurodevelopment; University of Missouri
Columbia, Missouri, 65211, United States
-
University of Iowa
Iowa City, Iowa, 52242, United States
-
University of Massachusetts Chan Medical School
Worcester, Massachusetts, 01655, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States